D57.40
Sickle-cell thalassemia without crisis
Clinical Classification Guidelines
Inclusion Terms
- Microdrepanocytosis
- Sickle-cell thalassemia NOS
Medical Intelligence & Overview
Sickle-cell thalassemia without crisis is a blood disorder characterized by abnormal hemoglobin, the protein in red blood cells that carries oxygen throughout the body. This condition involves a combination of sickle-shaped cells and thalassemia traits, leading to challenges in oxygen delivery without the occurrence of acute sickle-cell crises. Unlike more severe forms, this type often manifests with milder symptoms and fewer complications, but it still requires careful management to maintain good health.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations that affect hemoglobin production Presence of genes responsible for both sickle-cell disease and thalassemia Microdrepanocytosis, a mild form of sickle-cell trait where some red blood cells are abnormally shaped Genetic variations that influence how hemoglobins are produced within red blood cells
Key Symptoms: Mild anemia, leading to fatigue or weakness Delayed growth and development in children Slight jaundice or yellowing of the skin and eyes After physical exertion, mild shortness of breath or tiredness Reduced exercise tolerance Possible episodes of mild discomfort or pain, but not prolonged or severe Absence of frequent or severe sickling crises
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves blood tests such as a complete blood count (CBC) and hemoglobin electrophoresis. These tests identify abnormal hemoglobin types and help differentiate between various hemoglobinopathies. Genetic testing may also be used to confirm the presence of mutations associated with sickle-cell thalassemia. Because the condition is often mild, detection may occur during screening or evaluation for anemia. Microdrepanocytosis, in particular, is identified through specialized blood analysis showing a low percentage of sickle-shaped cells.
Treatment Protocols: Folate supplements to support red blood cell production Adequate hydration and avoiding extreme dehydration Prompt treatment of infections to prevent complications Managing anemia with transfusions if necessary, in more severe cases Counseling and genetic testing for affected families Lifestyle modifications, such as avoiding extreme physical exertion and maintaining a healthy diet
Clinical Advice & FAQs
Billing Guidance
Is D57.40 a billable ICD-10 code?
Yes, D57.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.40?
Clinical documentation must specify the nature of Sickle-cell thalassemia without crisis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference